Rite Aid Corp (NYSE:RAD)
| CAPS Rating |
|
|---|---|
| Open | $1.57 |
| Previous Close | $1.59 |
| Daily Range | $1.54 - $1.58 |
| 52-Week Range | $0.85 - $1.61 |
| Market Cap | $1.38B |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 3,449,391 |
| Average Daily Volume | 0 |
RAD
VS S&P 500 (SPY)
How do you think RAD will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
RAD Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
RAD News and Commentary
- Is Rite Aid a Buffett Stock? – The Motley Fool
- CVS Caremark Earnings: Express-Walgreen Dispute Bodes Well For CVS – Trefis
- Rite Aid’s January Sales Show Steady Eddy Growth – Trefis
- Can These Stocks Bounce Higher? – The Motley Fool
- CVS Caremark Earnings Preview: What We’re Watching – Trefis
- Rite Aid Posts Strong January Comps - Analyst Blog – NASDAQ
- Walgreen Says Goodbye to Express Scripts and Its Customers – The Motley Fool
- Consolidated Summary Of January Retail-Sales Results – SmartMoney
- 3 Drug Stores for Short Term Traders – NASDAQ
- WellPoint Cites Positive Talks In Express Scripts Dispute – SmartMoney
- CVS Caremark: Geared Up for Strong 2012 Growth – Trefis
- Does CVS Caremark Pass Buffett's Test? – The Motley Fool
- CVS Gains from Walgreen, Express Scripts Break Up – Trefis
- Walgreen Looks to Cut Fat in 2012 After Express Scripts Exit – Trefis
- Walgreen Updates: Express Scripts & Weak Flu Season Weigh on Outlook – Trefis
- Rite Aid’s Raised 2012 Outlook Supports $1.45 Value – Trefis
- Is Rite Aid Hiding Weakness? – The Motley Fool
- Walgreen Update: Weak December Sales, Fair Value $35 – Trefis
- Does Rite Aid Measure Up? – The Motley Fool
- Rite Aid December Sales Justify $1.45 Fair Value – Trefis
RSS Headlines
Fool UK
